218 related articles for article (PubMed ID: 10469011)
21. P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer.
Ficorella C; Cannita K; Ricevuto E; Toniato E; Fusco C; Sinopoli NT; De Galitiis F; Di Rocco ZC; Porzio G; Frati L; Gulino A; Martinotti S; Marchetti P
Oncol Rep; 2003; 10(1):169-73. PubMed ID: 12469165
[TBL] [Abstract][Full Text] [Related]
22. Identification of G protein alpha subunit mutations in human growth hormone (GH)- and GH/prolactin-secreting pituitary tumors by single-strand conformation polymorphism (SSCP) analysis.
Drews RT; Gravel RA; Collu R
Mol Cell Endocrinol; 1992 Sep; 87(1-3):125-9. PubMed ID: 1446784
[TBL] [Abstract][Full Text] [Related]
23. Abundant hypermethylation of SOCS-1 in clinically silent pituitary adenomas.
Buslei R; Kreutzer J; Hofmann B; Schmidt V; Siebzehnrübl F; Hahnen E; Eyupoglu IY; Fahlbusch R; Blümcke I
Acta Neuropathol; 2006 Mar; 111(3):264-71. PubMed ID: 16421738
[TBL] [Abstract][Full Text] [Related]
24. p53 gene mutations in pituitary adenomas: rare events.
Levy A; Hall L; Yeudall WA; Lightman SL
Clin Endocrinol (Oxf); 1994 Dec; 41(6):809-14. PubMed ID: 7889618
[TBL] [Abstract][Full Text] [Related]
25. Hypermethylation of the p16/CDKN2A/MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas.
Simpson DJ; Bicknell JE; McNicol AM; Clayton RN; Farrell WE
Genes Chromosomes Cancer; 1999 Apr; 24(4):328-36. PubMed ID: 10092131
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
[TBL] [Abstract][Full Text] [Related]
27. Alterations of tumor suppressor gene p16INK4a in pancreatic ductal carcinoma.
Attri J; Srinivasan R; Majumdar S; Radotra BD; Wig J
BMC Gastroenterol; 2005 Jun; 5():22. PubMed ID: 15985168
[TBL] [Abstract][Full Text] [Related]
28. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
Herman V; Drazin NZ; Gonsky R; Melmed S
J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
[TBL] [Abstract][Full Text] [Related]
29. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
[TBL] [Abstract][Full Text] [Related]
30. The GnRH receptor gene is preferentially expressed in functioning gonadotroph adenomas and displays a Mae III polymorphism site.
Kottler ML; Seret-Bégué D; Lahlou N; Assayag M; Carré MC; Lagarde JP; Ajzenberg C; Christin-Maitre S; Bouchard P; Mikol J; Counis R; Warnet A
Clin Endocrinol (Oxf); 1998 Jul; 49(1):115-23. PubMed ID: 9797855
[TBL] [Abstract][Full Text] [Related]
31. Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer.
Vallian S; Sedaghat M; Nassiri I; Frazmand A
J Cancer Res Clin Oncol; 2009 Aug; 135(8):991-6. PubMed ID: 19125298
[TBL] [Abstract][Full Text] [Related]
32. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
33. Oncogene-induced senescence in pituitary adenomas and carcinomas.
Alexandraki KI; Munayem Khan M; Chahal HS; Dalantaeva NS; Trivellin G; Berney DM; Caron P; Popovic V; Pfeifer M; Jordan S; Korbonits M; Grossman AB
Hormones (Athens); 2012; 11(3):297-307. PubMed ID: 22908062
[TBL] [Abstract][Full Text] [Related]
34. The IGF-I receptor sub-membrane domain is intact in GH-secreting pituitary tumours.
Greenman Y; Prager D; Melmed S
Clin Endocrinol (Oxf); 1995 Feb; 42(2):169-72. PubMed ID: 7704960
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathology shows p16 methylation in nonadenomatous pituitaries from patients with Cushing's disease.
Simpson DJ; McNicol AM; Murray DC; Bahar A; Turner HE; Wass JA; Esiri MM; Clayton RN; Farrell WE
Clin Cancer Res; 2004 Mar; 10(5):1780-8. PubMed ID: 15014032
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas.
Simpson DJ; Frost SJ; Bicknell JE; Broome JC; McNicol AM; Clayton RN; Farrell WE
Carcinogenesis; 2001 Aug; 22(8):1149-54. PubMed ID: 11470742
[TBL] [Abstract][Full Text] [Related]
37. Abnormalities of tumor suppressor gene p16 in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters.
Ohtsubo K; Watanabe H; Yamaguchi Y; Hu YX; Motoo Y; Okai T; Sawabu N
J Gastroenterol; 2003; 38(7):663-71. PubMed ID: 12898359
[TBL] [Abstract][Full Text] [Related]
38. High frequency of p16INK4A gene alterations in hepatocellular carcinoma.
Liew CT; Li HM; Lo KW; Leow CK; Chan JY; Hin LY; Lau WY; Lai PB; Lim BK; Huang J; Leung WT; Wu S; Lee JC
Oncogene; 1999 Jan; 18(3):789-95. PubMed ID: 9989830
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the Gs alpha gene in growth hormone-secreting pituitary adenomas by the polymerase chain reaction-direct sequencing method using paraffin-embedded tissues.
Hosoi E; Yokogoshi Y; Hosoi E; Horie H; Sano T; Yamada S; Saito S
Acta Endocrinol (Copenh); 1993 Oct; 129(4):301-6. PubMed ID: 8237246
[TBL] [Abstract][Full Text] [Related]
40. Absence of mutations in exon 3 of the GnRH receptor in human gonadotroph adenomas.
Kaye PV; Hapgood J; Millar RP
Clin Endocrinol (Oxf); 1997 Nov; 47(5):549-54. PubMed ID: 9425394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]